About The Horseracing Integrity Act of 2017:

Today, there is no national independent and science-based organization in horse racing dedicated to protecting athlete safety and racing integrity and to ensuring a level playing field for competition. The Horseracing Integrity Act of 2017, sponsored by Reps. Andy Barr (R-KY) and Paul Tonko (D-NY), addresses this pressing need. The bill grants authority for developing and administering an anti-doping program for horse racing to the Horseracing Anti-Doping and Medication Control Authority.

The authority would be governed by a board composed of the chief executive officer of the United States Anti-Doping Agency (USADA), six individuals from the USADA board, and six individuals selected by USADA who have demonstrated expertise in a variety of horse-racing areas. The Federal Trade Commission would have limited oversight of the authority.

The authority will establish permitted and prohibited lists of medications, naturally and synthetically occurring substances, and treatment methods. The bill requires that the authority prohibit the use of medication within 24 hours of a race no later than January 1, 2019.

The authority will have the opportunity to work collaboratively with state racing commissions and their respective staff members throughout the country, and the authority will be funded entirely by the industry.

Tell a Friend

Help spread our clean racing mission with others who may share your views.